CDRH Problematic Regulatory Paths Review On Near-Term Agenda – Feigal
This article was originally published in The Gray Sheet
Executive Summary
The Center for Devices & Radiological Health already is moving to implement agency-wide initiatives that seek to provide guidance for manufacturers of novel products, according to FDA officials